PRM:LSE Proteome Sciences PLC

GBX 4.50 0.00 0
Icon

Proteome Sciences PLC (PRM:LSE) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 4.50

0.00 (0.00)%

GBX 0.02B

0.05M

N/A

N/A

Icon

PRM:LSE

Proteome Sciences PLC (GBX)
COMMON STOCK | LSE
GBX 4.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.02B

N/A

GBX 4.50

Proteome Sciences PLC (PRM:LSE) Stock Forecast

N/A

Based on the Proteome Sciences PLC stock forecast from 0 analysts, the average analyst target price for Proteome Sciences PLC is not available over the next 12 months. Proteome Sciences PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Proteome Sciences PLC is Bullish , which is based on 5 positive signals and 2 negative signals. At the last closing, Proteome Sciences PLC’s stock price was GBX 4.50. Proteome Sciences PLC’s stock price has changed by +2.27% over the past week, +3.45% over the past month and +0.45% over the last year.

No recent analyst target price found for Proteome Sciences PLC
No recent average analyst rating found for Proteome Sciences PLC

Company Overview Proteome Sciences PLC

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activit...Read More

https://www.proteomics.com

Coveham House, Cobham, United Kingdom, KT11 3EP

29

December

GBX

UK

Adjusted Closing Price for Proteome Sciences PLC (PRM:LSE)

Loading...

Unadjusted Closing Price for Proteome Sciences PLC (PRM:LSE)

Loading...

Share Trading Volume for Proteome Sciences PLC Shares

Loading...

Compare Performance of Proteome Sciences PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PRM:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Proteome Sciences PLC (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDHC:LSE
Integrated Diagnostics Holding.. 0.00 (0.00%) GBX0.21B 0.17 0.25

ETFs Containing PRM

Symbol Name PRM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Proteome Sciences PLC (PRM:LSE) Stock

Stock Target Advisor's fundamental analysis for Proteome Sciences PLC's stock is Bullish .

PRM:LSE stock's dividend yield is 6.17%. Our analysis grades PRM:LSE stock's dividend yield at C. This means that PRM:LSE stock's dividend yield is above 75% of the stocks in the Diagnostics & Research sector in the LSE exchange. Based on this PRM:LSE may be a average dividend stock for its sector.

Unfortunately we do not have enough data on PRM:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PRM:LSE's stock to indicate if its overvalued.

The last closing price of PRM:LSE's stock was GBX 4.50.

The most recent market capitalization for PRM:LSE is GBX 0.02B.

Unfortunately we do not have enough analyst data on PRM:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Proteome Sciences PLC's stock.

As per our most recent records Proteome Sciences PLC has 29 Employees.

Proteome Sciences PLC's registered address is Coveham House, Cobham, United Kingdom, KT11 3EP. You can get more information about it from Proteome Sciences PLC's website at https://www.proteomics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...